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Abstract: The development of a novel route for the synthesis of a new class of compounds 
is described. The first tripodal, tris-indole amines are prepared by straightforward routes. 
Keywords: Indole, TRENSOX, iron chelation. 
 
Introduction 
Recent research in the area of oral iron-chelation therapy centers on the TRENSOX drugs. Both 
N-TRENSOX (1) [1] and O-TRENSOX (2) [2] have shown promising results in iron binding and 
water solubility studies [3]. These novel compounds contain three quinoline units which each contain 
two oxygen functional groups.  The oxygen atoms are located in such a way to provide the six 





































Due to their wide range of biological activities, indole and its derivatives continue to serve as 
important synthetic targets [4].  3-Substituted indoles [5], particularly 3-acylindoles [6], are commonly 
found in pharmaceutical agents and are important synthetic intermediates.  
 
Results and Discussion 
Here, we describe the preliminary results toward the synthesis of two new TRENSOX derivatives, 
containing indole units in place of the quinolines. We have previously shown that indole-3-glyoxalyl 
chloride (3) will react with tris(2-aminoethyl)amine (TREN) to produce a  3-armed, claw-like structure 
(4) (Scheme 1) [7]. The tripodal amine appears to be fluxional in solution, as seen by NMR, and 
tightly closed as a solid, as seen by x-ray diffraction. To prepare the derivative, indole was first reacted 
with oxalyl chloride, and the resulting glyoxalyl chloride was added to TREN and triethylamine (TEA) 
in THF. After 24 hours, the resulting slurry was filtered, crystallized from methanol and filtered again 
































Having established the success in the preparation of the first member in this new class of 
compounds, a related tripodal amine (5) with one carbonyl unit per arm was also been prepared by a 
modification of the above procedure. As seen in Scheme 2, indole-3-carboxylic acid was reacted with 






























The temperature of the reactions at the point when TREN is added seems to have a significant 
impact on the success of the reactions.  Several attempts to add TREN at room temperature resulted in 
dark-colored gums, while additions in an ice bath gave relatively clean products. The rapidity of the 




We have developed a facile method for the synthesis of two novel tris-indolyl amines. These 
tripodal compounds are important intermediates in the development of new drugs with potential iron-
chelating abilities. As efforts to improve the water-solubility of these compounds are underway, the 




Melting points are uncorrected. 1H-NMR spectra were obtained using a Bruker 250 MHz multi-
nuclear spectrometer. MS were measured using a Shimadzu QP 5050A instrument. 
 
Tris(2-[indole-3-glyoxylamido]ethyl)amine (4).  To indole (10.07 g, 86.1 mmol) in ether (200 mL) was 
added dropwise oxalyl choride (14.6 g, 114.6 mmol) over 15 mins. After stirring for 30 min, the 
solution was filtered to yield 3 as a yellow solid, which was rapidly dissolved in THF (50 mL).  To 3 
in THF at 0°C was added a solution of TREN (6.14 g, 42.0 mmol) and TEA (42.3 mmol) in THF (10 
mL). After stirring at 0°C for 1 h, the solution was filtered and the filtrate was evaporated to yield 4 as 
a beige solid which crystallized from MeOH. Yield 5.93 g (31.4%);  mp > 250°C. 1H-NMR (250 MHz, 
DMSO-d6) 8.75 (s, 3H, H2), 8.65 (t,  J=5.29 Hz, 3H, H1), 8.14 (d,  J=6.9 Hz, 3H, H4), 7.47 (d, J=7.1 
Hz, 3H, H7), 7.22 (t, J=7.0 Hz, 3H, H5 or H6), 7.16 (t, J=7.0 Hz, 3H, H6 or H5), 3.31 (m, 6H, Ha), 2.71 
(bt, 6H, Hb);  MS (M+1)+ = 660 for C36H33N7O6 
 
Tris(2-[indole-3-amido]ethyl)amine (5).  Indole-3-carboxylic acid (0.56 g, 3.4 mmol) dissolved in 
SOCl2 (6 mL) was stirred at 0°C. After 1.5 h, the solution was rotary evaporated, and to the resulting 
oil was added TREN (0.62 g, 4.2 mmol) and TEA (0.46 g, 4.6 mmol) in THF (25 mL).  After stirring 
at 0°C for 30 min, the solution was vacuum filtered to yield 5 as a beige solid which was recrystallized 
from MeOH.  Yield  0.28 g (43.0%);  mp > 250°C. 1H-NMR (250 MHz, DMSO-d6) 7.98 (s, 3H, H2), 
7.44 (m, 3H, H1), 7.17 (m, 3H, H4), 7.15 (d, 3H, H7), 7.14 (m, 3H, H5 or H6), 7.12 (m, 3H, H6 or H5), 
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